Record Revenue Growth
Paysign reported record revenue of $19.1 million, up 33% compared to the second quarter last year, demonstrating significant growth momentum.
Improved Gross Margins
Gross margins improved by 870 basis points to 61.6%, indicating enhanced operational efficiency.
Doubling Adjusted EBITDA
Adjusted EBITDA doubled to $4.5 million, up 102% from the second quarter of 2024.
Significant Growth in Patient Affordability Business
Revenue from the patient affordability business grew 190% year-over-year to $7.75 million, with revenue per program rising over 83%.
Expansion of Plasma Centers
Paysign onboarded 123 of the 132 plasma centers awarded, increasing their market share to approximately 50%.
Introduction of New Software Solutions
Paysign introduced a new Software-as-a-Service engagement platform for the plasma industry, receiving positive feedback domestically and internationally.